These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 18627275)

  • 1. Family experiences with pediatric antiretroviral therapy: responsibilities, barriers, and strategies for remembering medications.
    Marhefka SL; Koenig LJ; Allison S; Bachanas P; Bulterys M; Bettica L; Tepper VJ; Abrams EJ
    AIDS Patient Care STDS; 2008 Aug; 22(8):637-47. PubMed ID: 18627275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to medication regimens among children with human immunodeficiency virus infection.
    Reddington C; Cohen J; Baldillo A; Toye M; Smith D; Kneut C; Demaria A; Bertolli J; Hsu HW
    Pediatr Infect Dis J; 2000 Dec; 19(12):1148-53. PubMed ID: 11144374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to prescribed antiretroviral therapy in human immunodeficiency virus-infected children in the PENTA 5 trial.
    Gibb DM; Goodall RL; Giacomet V; McGee L; Compagnucci A; Lyall H;
    Pediatr Infect Dis J; 2003 Jan; 22(1):56-62. PubMed ID: 12544410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barriers to medication adherence in HIV-infected children and youth based on self- and caregiver report.
    Buchanan AL; Montepiedra G; Sirois PA; Kammerer B; Garvie PA; Storm DS; Nichols SL
    Pediatrics; 2012 May; 129(5):e1244-51. PubMed ID: 22508915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to combination antiretroviral treatment in children.
    Pontali E; Feasi M; Toscanini F; Bassetti M; De Gol P; Nuzzolese A; Bassetti D
    HIV Clin Trials; 2001; 2(6):466-73. PubMed ID: 11742434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of psychosocial and family factors in adherence to antiretroviral treatment in human immunodeficiency virus-infected children.
    Mellins CA; Brackis-Cott E; Dolezal C; Abrams EJ
    Pediatr Infect Dis J; 2004 Nov; 23(11):1035-41. PubMed ID: 15545859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Achieving adherence with antiretroviral medications for pediatric HIV disease.
    Byrne M; Honig J; Jurgrau A; Heffernan SM; Donahue MC
    AIDS Read; 2002 Apr; 12(4):151-54, 161-4. PubMed ID: 12071185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors related to antiretroviral therapy adherence in children and adolescents with HIV/AIDS in Cuba.
    Castro M; González I; Pérez J
    MEDICC Rev; 2015 Jan; 17(1):35-40. PubMed ID: 25725767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disclosure of HIV status and adherence to daily drug regimens among HIV-infected children in Uganda.
    Bikaako-Kajura W; Luyirika E; Purcell DW; Downing J; Kaharuza F; Mermin J; Malamba S; Bunnell R
    AIDS Behav; 2006 Jul; 10(4 Suppl):S85-93. PubMed ID: 16791525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to antiretroviral therapy among older children and adolescents with HIV: a qualitative study of psychosocial contexts.
    Merzel C; VanDevanter N; Irvine M
    AIDS Patient Care STDS; 2008 Dec; 22(12):977-87. PubMed ID: 19072104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caregiver-reported antiretroviral therapy non-adherence during the first week and after a month of treatment initiation among children diagnosed with HIV in Ethiopia.
    Biru M; Jerene D; Lundqvist P; Molla M; Abebe W; Hallström I
    AIDS Care; 2017 Apr; 29(4):436-440. PubMed ID: 27842440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy, safety, and adherence with a twice-daily combination lamivudine/zidovudine tablet formulation, plus a protease inhibitor, in HIV infection.
    Eron JJ; Yetzer ES; Ruane PJ; Becker S; Sawyer GA; Fisher RL; Tolson JM; Shaefer MS
    AIDS; 2000 Apr; 14(6):671-81. PubMed ID: 10807190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Patient Medication Adherence Questionnaire as a tool for self-reported adherence assessment in HIV-infected patients on antiretroviral regimens.
    Duong M; Piroth L; Grappin M; Forte F; Peytavin G; Buisson M; Chavanet P; Portier H
    HIV Clin Trials; 2001; 2(2):128-35. PubMed ID: 11590521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to antiretroviral medications in an inner-city population.
    Weidle PJ; Ganera CE; Irwin KL; McGowan JP; Ernst JA; Olivo N; Holmberg SD
    J Acquir Immune Defic Syndr; 1999 Dec; 22(5):498-502. PubMed ID: 10961612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of and adherence to highly active antiretroviral therapy in children infected with human immunodeficiency virus type 1.
    Watson DC; Farley JJ
    Pediatr Infect Dis J; 1999 Aug; 18(8):682-9. PubMed ID: 10462336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical assessment of medication adherence among HIV-infected children: examination of the Treatment Interview Protocol (TIP).
    Marhefka SL; Farley JJ; Rodrigue JR; Sandrik LL; Sleasman JW; Tepper VJ
    AIDS Care; 2004 Apr; 16(3):323-38. PubMed ID: 15203426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating adherence to highly active antiretroviral therapy into children's daily lives: a qualitative study.
    Hammami N; Nöstlinger C; Hoerée T; Lefèvre P; Jonckheer T; Kolsteren P
    Pediatrics; 2004 Nov; 114(5):e591-7. PubMed ID: 15520091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretroviral therapy in the year 2000.
    Tashima KT; Flanigan TP
    Infect Dis Clin North Am; 2000 Dec; 14(4):827-49. PubMed ID: 11144641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors affecting antiretroviral drug adherence among HIV/AIDS adult patients attending HIV/AIDS clinic at Moi Teaching and Referral Hospital, Eldoret, Kenya.
    Talam NC; Gatongi P; Rotich J; Kimaiyo S
    East Afr J Public Health; 2008 Aug; 5(2):74-8. PubMed ID: 19024414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient, caregiver and regimen characteristics associated with adherence to highly active antiretroviral therapy among HIV-infected children and adolescents.
    Martin S; Elliott-DeSorbo DK; Wolters PL; Toledo-Tamula MA; Roby G; Zeichner S; Wood LV
    Pediatr Infect Dis J; 2007 Jan; 26(1):61-7. PubMed ID: 17195708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.